PRESS RELEASE
News
-
-
PRESS RELEASE
Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis
FDA designates tolebrutinib as Breakthrough Therapy for non-relapsing SPMS based on positive HERCULES study results. Sanofi awaits regulatory review for this innovative medicine -
PRESS RELEASE
Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées
Le tolebrutinib reçoit la désignation 'Médicament innovant' de la FDA pour traiter la SEP-SP sans poussées, grâce aux résultats positifs de l'étude HERCULES. Sanofi prévoit de finaliser les soumissions réglementaires aux États-Unis et en Europe -
PRESS RELEASE
mobilezone lowers earnings forecast for 2024 – One-off effects and adjustments – Dividend of CHF 0.90 per registered share confirmed – Video conference today at 09.15 a.m.
mobilezone lowers earnings forecast for 2024 due to one-off effects and adjustments, impacting sales and profitability in Germany and Switzerland -
-
PRESS RELEASE
Loop Industries Completes Convertible Preferred Financing With Reed Societe Generale Group and Sells First Technology License For An Infinite Loop Manufacturing Facility in Europe
Loop Industries secures €10 million investment and technology license, advancing circular plastics economy with Infinite Loop™ technology and European partnership -
PRESS RELEASE
Loop Industries Finalise Un Financement Convertible Privilégié Avec Reed Societe Generale Group Et Vend La Première Licence Technologique Pour Une Usine Infinite Loop En Europe
Reed Societe Generale investit 10 millions d'euros dans Loop pour une technologie durable de recyclage du plastique PET et fibre polyester T2T -
-
-
